MEDI Stock Overview
Develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for MEDI from our risk checks.
Medistim ASA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 170.50 |
52 Week High | NOK 303.00 |
52 Week Low | NOK 167.00 |
Beta | 0.83 |
11 Month Change | -13.89% |
3 Month Change | -8.33% |
1 Year Change | -38.89% |
33 Year Change | -34.30% |
5 Year Change | 30.15% |
Change since IPO | 1,555.34% |
Recent News & Updates
Recent updates
Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 04One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts
Nov 10What Does Medistim ASA's (OB:MEDI) Share Price Indicate?
Dec 14Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?
Sep 06A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)
Jun 14Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75
Apr 21Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year
Mar 31Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are
Mar 05Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 01Medistim (OB:MEDI) Is Reinvesting To Multiply In Value
Jan 11Medistim (OB:MEDI) Might Become A Compounding Machine
Sep 29Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today
Sep 07Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean
May 17Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 19Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 02Here's What You Should Know About Medistim ASA's (OB:MEDI) 1.1% Dividend Yield
Feb 19A Look Into Medistim's (OB:MEDI) Impressive Returns On Capital
Jan 21Have Insiders Been Selling Medistim ASA (OB:MEDI) Shares?
Dec 27Medistim (OB:MEDI) Has Rewarded Shareholders With An Exceptional 375% Total Return On Their Investment
Dec 10Could The Market Be Wrong About Medistim ASA (OB:MEDI) Given Its Attractive Financial Prospects?
Nov 23Shareholder Returns
MEDI | NO Medical Equipment | NO Market | |
---|---|---|---|
7D | -11.4% | -0.8% | 1.4% |
1Y | -38.9% | 3.9% | 7.5% |
Return vs Industry: MEDI underperformed the Norwegian Medical Equipment industry which returned 7.2% over the past year.
Return vs Market: MEDI underperformed the Norwegian Market which returned 7.4% over the past year.
Price Volatility
MEDI volatility | |
---|---|
MEDI Average Weekly Movement | 5.9% |
Medical Equipment Industry Average Movement | 5.7% |
Market Average Movement | 5.0% |
10% most volatile stocks in NO Market | 11.0% |
10% least volatile stocks in NO Market | 2.7% |
Stable Share Price: MEDI has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDI's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 151 | Kari Krogstad | www.medistim.com |
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis.
Medistim ASA Fundamentals Summary
MEDI fundamental statistics | |
---|---|
Market cap | NOK 3.12b |
Earnings (TTM) | NOK 102.54m |
Revenue (TTM) | NOK 525.64m |
30.5x
P/E Ratio5.9x
P/S RatioIs MEDI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDI income statement (TTM) | |
---|---|
Revenue | NOK 525.64m |
Cost of Revenue | NOK 111.36m |
Gross Profit | NOK 414.28m |
Other Expenses | NOK 311.74m |
Earnings | NOK 102.54m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 16, 2024
Earnings per share (EPS) | 5.60 |
Gross Margin | 78.81% |
Net Profit Margin | 19.51% |
Debt/Equity Ratio | 0% |
How did MEDI perform over the long term?
See historical performance and comparison